What Does Asbestosis Follow-Up Involve? Lung Tests, Imaging and Complication Checks

He still keeps the tape measure. Forty years of pipe lagging, boiler rooms and dusty ceiling voids, and the tool that outlasted the job now sits in a kitchen drawer beside a hospital letter. The letter says his scan shows early scarring in the lower lungs, consistent with asbestosis, and that he will be “kept under review.” What that review involves, and how worried he should be between appointments, is the part nobody explained.

That gap is common. People hear the word asbestosis and picture either a death sentence or a footnote. The reality of asbestosis follow up monitoring sits in between: a steady, structured rhythm of breathing tests, imaging and complication checks whose main job is to notice change early enough to act on it.

This article walks through what those visits actually measure, why the intervals vary, and which findings genuinely matter. It is written for the person holding the letter, and for the family member reading over their shoulder.

How asbestosis follow up monitoring works, and what actually happens at a visit

Asbestosis is scarring of the lung tissue caused by inhaled asbestos fibers. Once the diagnosis is made, follow-up has three jobs: measure how the lungs are working, look at how they appear on imaging, and screen for the complications that asbestos exposure makes more likely. Everything else at a visit hangs off those three tasks.

A typical appointment begins with talking, not testing. The clinician asks how far you can walk before stopping, whether stairs feel different from last time, how your cough behaves, and whether anything new has appeared, such as chest pain or unintended weight change. Because asbestosis progresses slowly, your own comparison with six or twelve months ago is often the most sensitive instrument in the room.

Then comes the examination. The clinician listens for fine crackles at the bases of the lungs, the dry “velcro” sound that scarred tissue makes as it opens on a breath. They look at the fingertips for clubbing, a rounding of the nail beds linked with long-standing lung disease, and they clip a pulse oximeter, a small fingertip sensor that estimates blood oxygen, sometimes before and after a short walk.

Breathing tests follow, usually in a lung function laboratory rather than the clinic room. Imaging may be ordered the same day or scheduled separately, depending on how long since the last scan and whether anything has changed.

The final part is the conversation about what the numbers mean. Mayo Clinic describes follow-up for asbestosis as regular lung function testing and chest imaging to detect changes over time, alongside attention to smoking, vaccination and oxygen needs. Stable results are genuinely good news, and the team will say so. Changing results trigger a closer look, not automatic alarm.

Why the lungs keep changing decades after the dust settled

The strangest fact about asbestosis is the timing. The exposure that caused it may have ended before some of the clinic staff were born. According to the NHS, symptoms usually develop 20 to 30 years after exposure, and Mayo Clinic places the range at roughly 10 to 40 years. Follow-up exists precisely because the disease does not stop when the exposure does.

The mechanism explains the lag. Asbestos fibers are long, thin and remarkably durable. When inhaled, the smallest reach the alveoli, the tiny air sacs where oxygen crosses into blood. The immune system’s cleanup cells, called macrophages, try to engulf the fibers and fail; the fibers are too long and do not dissolve. The frustrated cells release inflammatory signals year after year, and the surrounding tissue responds the only way it can, by laying down scar.

Scar tissue is stiff. A healthy lung expands like a balloon; a fibrotic lung expands more like a leather bag. It holds less air, and the thickened walls slow the passage of oxygen into blood. That is why the two signature test abnormalities in asbestosis are a smaller lung volume and a reduced gas transfer, and why both are measured at follow-up.

Fibers also migrate to the pleura, the double membrane lining the chest cavity, producing plaques, thickening and occasionally fluid. And because asbestos is a recognized carcinogen for all fiber types, according to the WHO, the same lungs carry a lifelong, elevated risk of lung cancer and mesothelioma, a cancer of the pleural lining.

So the disease is not one event but a slow process with several possible branches. Monitoring is the act of watching each branch, over years, with tools sensitive enough to notice a change before the person notices it themselves.

Who is usually offered structured follow-up, and who is asked to wait and watch

Structured monitoring is generally offered to anyone with a confirmed diagnosis of asbestosis, regardless of how mild it currently is. The reasoning is simple: the disease can progress, and the complications it predisposes to are serious enough that early detection changes the options on the table.

People with more advanced scarring, a falling gas transfer, low oxygen on exertion, or continued smoking are usually reviewed more closely. So are those with additional pleural disease, because pleural thickening can restrict breathing independently of the lung scarring.

A second group sits in a different category. These are people with a documented asbestos exposure but no scarring on imaging and normal breathing tests. They do not have asbestosis, and most specialist services describe their care as exposure surveillance rather than disease monitoring. The intervals are typically longer and the emphasis shifts toward cancer awareness, smoking cessation and knowing which new symptoms warrant a prompt visit. Being asked to “wait and watch” here is not neglect; it reflects the evidence that repeated scanning of people without disease brings radiation exposure and false alarms without a proven survival benefit for asbestosis itself.

A third group are people with pleural plaques alone. Plaques are patches of thickening on the pleura and are markers of exposure, not scarring of the lung. Cleveland Clinic notes that plaques by themselves usually do not cause symptoms. Many people with plaques are discharged from routine follow-up with clear written advice, because their lung tissue is not fibrotic.

Where you fall along this spectrum is a decision for the treating team, weighing imaging, breathing tests, exposure history and your own preferences. A reasonable question at the first visit is: which of these groups am I in, and what would move me to another?

Asbestosis lung function tests: what spirometry and gas transfer reveal

Lung function testing is the backbone of follow-up because it produces numbers that can be compared visit to visit. Two tests carry most of the weight.

Spirometry measures how much air you can blow out and how fast. You take the deepest breath you can and exhale hard into a tube connected to a sensor. The key value in asbestosis is the forced vital capacity, or FVC, the total volume you can force out. Scarring shrinks that volume, producing what clinicians call a restrictive pattern. The airways themselves are usually not narrowed, so the speed of exhalation is often preserved unless smoking has added chronic obstructive disease on top.

Gas transfer, also called diffusing capacity or DLCO, measures how easily a test gas moves from the air sacs into blood during a single breath hold. It is often the earliest number to fall in fibrotic lung disease, because thickened alveolar walls slow oxygen uptake before they noticeably reduce volume. A declining DLCO with a stable FVC is a pattern the team will watch carefully.

Some laboratories add full lung volumes, measured in a sealed booth, to confirm restriction, and a six-minute walk test, in which oxygen saturation and distance are recorded while you walk a measured corridor at your own pace. The walk test is more useful than it looks: a drop in oxygen on exertion can appear years before resting levels fall.

Results are reported as a percentage of the value predicted for your age, sex, height and ethnicity. Small changes between visits are normal measurement noise. Trends across several visits are what matter, which is one more reason to attend even when you feel unchanged. MedlinePlus lists pulmonary function tests among the standard investigations for asbestosis.

Chest X-ray versus high-resolution CT: what each scan is for

Imaging shows what breathing tests can only infer. Two tools dominate, and they are not interchangeable.

A chest X-ray is quick, widely available and low in radiation. Asbestosis chest X-ray findings classically include fine linear or reticular shadows in the lower zones, sometimes with pleural plaques along the chest wall or diaphragm. The weakness of X-ray is sensitivity: early scarring can be present on CT while the X-ray looks normal.

High-resolution CT, or HRCT, takes thin cross-sectional slices of the lungs and can show subpleural lines, curvilinear bands, honeycombing and traction on the airways, the detailed signatures of fibrosis. Mayo Clinic notes that CT scans provide greater detail than X-rays and may help detect asbestosis before it appears on a plain film. HRCT also characterizes pleural disease precisely and is the tool most likely to pick up a new nodule.

Feature	Chest X-ray	High-resolution CT
Radiation dose	Very low	Higher, though reduced by low-dose protocols
Detects early scarring	Often misses it	Much more sensitive
Pleural plaques and thickening	Visible when calcified or large	Seen in fine detail
New nodules or masses	Limited	Preferred tool
Typical role in follow-up	Routine interval check	Baseline, change in symptoms, falling test results

Most teams do not repeat HRCT at every visit. The scan is usually reserved for a baseline, for a change in symptoms or lung function, or for clarifying something seen on X-ray. Radiation exposure from CT is small per scan but accumulates, and the team balances that against the value of the information. If you are unsure why a particular scan was or was not ordered, ask; the reasoning is usually straightforward.

Does asbestosis show up in a blood test?

No. There is no blood test that diagnoses asbestosis or measures how much scarring is present. Fibrosis is a structural change in tissue, and blood tests reflect chemistry, cells and immune markers, not architecture. The diagnosis rests on exposure history, imaging and lung function, and follow-up relies on the same three pillars.

That said, blood tests do appear in follow-up care for narrower reasons. An arterial blood gas, a sample taken from an artery usually at the wrist, gives a precise reading of oxygen and carbon dioxide levels when a fingertip oximeter suggests they are low. MedlinePlus lists this among the tests used in asbestosis. It helps the team judge whether supplemental oxygen is needed and whether carbon dioxide is being retained, which can happen in advanced disease.

Routine blood counts and kidney and liver tests may be done before procedures or when starting treatments that require monitoring. A raised red cell count can hint at chronic low oxygen. None of these is a test “for” asbestosis; they are tests around it.

Research groups have studied blood markers such as mesothelin and fibulin-3 as possible early signals of mesothelioma in people exposed to asbestos. Current evidence does not support their use for routine screening, because they miss many cancers and flag many people who do not have one. If a clinical trial offers such a test, that is a legitimate research setting; it is not part of standard follow-up.

The practical message for the person in clinic: if blood is taken, ask what it is for. It will be about oxygen, fitness for a procedure or general health, never a verdict on the lungs themselves.

First signs of asbestosis and the lung findings clinicians track over time

People often ask what the first signs of asbestosis are, and the honest answer is that the earliest sign is usually not a symptom at all but a scan finding in someone being checked because of their work history. When symptoms do arrive, the NHS describes breathlessness on exertion, a persistent cough and, in some people, fatigue and chest tightness. These develop gradually, over years, which is why they are easy to attribute to age or fitness.

Rather than a checklist for self-diagnosis, it helps to understand what clinicians are tracking and why. Breathlessness is graded by activity: can you keep pace with people your age on flat ground, do you stop on a gentle hill, do you pause for breath after one flight of stairs. A shift down that scale between visits is meaningful even when the breathing tests look similar.

On examination, the common lung findings are bibasal fine crackles that do not clear with coughing, reduced chest expansion, and in longer-standing disease, finger clubbing. Cleveland Clinic lists crackling sounds and clubbing among the physical signs associated with asbestosis.

On imaging, the recurring pattern is scarring concentrated in the lower and peripheral parts of the lungs, often accompanied by pleural plaques. On lung function, it is a shrinking FVC and a falling gas transfer.

These findings are also seen in other fibrotic lung diseases, which is why the exposure history matters so much at diagnosis and why the team may reconsider the label if the pattern evolves unusually. Follow-up is partly a continuing check that the original diagnosis still fits the picture.

Complication checks: pleural disease, lung cancer and mesothelioma

The scarring itself is only one of the things being monitored. Asbestos exposure raises the risk of several distinct conditions, and follow-up is designed to notice each.

Pleural disease comes in several forms. Plaques are flat, often calcified patches and are usually harmless in themselves. Diffuse pleural thickening is more extensive and can encase the lung, restricting expansion in a way that adds to the breathlessness from fibrosis. Benign asbestos pleural effusion, a collection of fluid between the pleural layers, can appear years after exposure and may need drainage and analysis to rule out cancer.

Lung cancer risk is elevated in anyone with significant asbestos exposure, and Mayo Clinic notes that smoking multiplies that risk rather than simply adding to it. This is the single most important modifiable factor in the entire follow-up plan. Imaging at review is read with cancer in mind: any new nodule, mass or unexplained collapse of a lung segment is investigated rather than assumed to be scar.

Mesothelioma is a cancer of the pleural lining strongly linked to asbestos. It typically presents with chest wall pain, breathlessness from effusion or unexplained weight loss, often decades after exposure. There is no proven screening test that reduces deaths from mesothelioma, which is why follow-up depends on prompt reporting of new symptoms and on careful imaging when they occur.

Whether people with asbestosis should be offered low-dose CT lung cancer screening is decided individually. Eligibility criteria in many programs rest on age and smoking history; asbestos exposure may strengthen the case. Ask the team whether you qualify and what a positive result would trigger, so that the decision is informed rather than reflexive.

Complication checks: oxygen, heart strain and infection

Scarring that restricts oxygen uptake has consequences beyond the lungs, and a good follow-up plan looks for them.

Low oxygen, called hypoxemia, is checked at every visit with the fingertip oximeter and, when needed, with an arterial blood gas or an overnight oximetry study at home. Oxygen levels often fall first during exertion or sleep, which is why the six-minute walk test and overnight monitoring can be more informative than a resting reading. Persistently low levels are the trigger for discussing supplemental oxygen, a decision the treating team makes on measured values rather than on how breathless someone feels.

Chronic low oxygen narrows the blood vessels in the lungs, raising the pressure the right side of the heart must pump against. Over years this can lead to pulmonary hypertension and, eventually, strain on the right ventricle, sometimes called cor pulmonale. The team watches for ankle swelling, a raised neck vein pattern and certain changes on an electrocardiogram; an echocardiogram, an ultrasound of the heart, may be ordered to estimate pulmonary pressures. Mayo Clinic lists heart problems of this kind among the complications of advanced asbestosis.

Infection matters because a scarred lung has less reserve. A chest infection that a healthy person shrugs off can tip someone with asbestosis into respiratory failure, a state in which the lungs can no longer maintain adequate oxygen and carbon dioxide levels. Follow-up therefore includes a check that recommended vaccinations, such as influenza and pneumococcal vaccines, are up to date, in line with NHS advice for people with long-term lung conditions.

None of these checks is dramatic. Together they form an early-warning system for the problems that most often change a stable picture into an urgent one.

How often should asbestosis follow-up monitoring be conducted?

This is the most searched question about asbestos medical exams, and the honest answer is that no single interval applies to everyone. The NHS describes regular check-ups to monitor the condition, and Mayo Clinic describes repeated lung function tests and imaging at intervals set by the care team. Neither fixes a number, and that is deliberate: the right frequency depends on how advanced the disease is and how fast it is moving.

In practice, many services review stable, mild disease roughly once a year, with breathing tests at each visit and imaging less often. People with progressive symptoms, falling gas transfer, exertional desaturation or new pleural changes are commonly seen more frequently, sometimes every few months while a change is being characterized. Those with exposure but no disease are often reviewed at longer intervals or discharged with written advice. These are patterns of practice, not rules, and the interval on your letter should reflect your results.

Frequency also changes over time. A run of stable results can justify stretching the gap; a single unexpected change can justify shortening it. Ask the team what specific finding would prompt them to bring you back sooner, so that you know the plan rather than simply the date.

Between appointments, the most valuable form of monitoring is your own. Keep a note of what you can comfortably do, and mention any change in exertional tolerance, cough character, chest pain or weight, even if the next visit is months away. Follow-up intervals assume that new symptoms will be reported when they arise, not saved for the next scheduled slot.

What the results change about treatment

People sometimes ask why they should attend follow-up when asbestosis has no treatment that reverses scarring. The premise is right; the conclusion is not. Monitoring changes management in several concrete ways.

Smoking cessation is the intervention with the largest evidence base. Because asbestos and tobacco multiply lung cancer risk, and because smoking also accelerates loss of lung function, every review is an opportunity to offer structured support. The team may discuss behavioral programs and medicines in the nicotine replacement and smoking cessation classes; the choice and prescription sit with the prescribing clinician.

Oxygen therapy is prescribed on measured criteria. A follow-up that documents low oxygen at rest, on exertion or overnight is the pathway to supplemental oxygen, which relieves breathlessness in some people and protects the heart from the effects of chronic hypoxemia. Without monitoring, that threshold is missed.

Pulmonary rehabilitation, a supervised program of exercise training, breathing techniques and education, is offered to people limited by breathlessness from chronic lung disease. Mayo Clinic lists it among supportive measures for asbestosis. Follow-up identifies when someone would benefit.

Vaccination status is checked and updated. Chest infections are treated early and, when a bacterial cause is suspected, with antibiotics chosen by the treating clinician.

In a small number of people with severe, progressive disease, monitoring data support a referral for lung transplant assessment, a decision that depends on many factors beyond the lungs.

Antifibrotic medicines, a class that slows scarring in some other fibrotic lung diseases, are not established for asbestosis; evidence is limited to small studies. A specialist may discuss this in the context of a trial. Nothing here is a reason to start, stop or change any medicine on your own.

The weeks after a review, and the natural course of lung function decline

Most follow-up appointments end quietly. The breathing tests are similar to last time, the X-ray is unchanged, and you leave with the same interval as before. The days afterward involve little beyond making sure the next date is in the calendar and any letter to your primary care clinician has arrived.

When something has changed, the following weeks look different. A falling gas transfer or a new shadow on X-ray usually leads to an HRCT within a few weeks, sometimes with an echocardiogram or overnight oximetry alongside. A new pleural effusion may lead to a drainage procedure and fluid analysis. A new nodule may be discussed at a multidisciplinary meeting, where radiologists, chest physicians and, if needed, cancer specialists agree a plan. Waiting for these results is the hardest part; asking at the outset how and when you will hear back reduces the anxiety considerably.

What does the longer course look like? Asbestosis is generally slowly progressive, and the NHS notes that the condition can worsen over time, although the pace varies widely between individuals. Some people show almost no measurable change over many years; others decline steadily. Higher cumulative exposure, more extensive scarring at diagnosis and continued smoking are associated with faster decline. Because the range is so broad, no clinician can honestly promise a trajectory, and any figure you read online about “average” decline says little about your own lungs.

The purpose of repeated testing is to define your personal curve. Three or four data points, a couple of years apart, tell the team far more than any population statistic, and they turn follow-up from a ritual into a genuinely individual plan.

What people often get wrong about asbestosis follow-up

Misunderstandings cluster around a few themes, and correcting them changes how people engage with their care.

“Asbestosis is a form of cancer.” It is not. Asbestosis is scarring, a benign process in the pathological sense, even though it can be disabling. Lung cancer and mesothelioma are separate conditions that share the same cause. Follow-up watches for them because the risk is raised, not because asbestosis turns into them.

“Pleural plaques mean I have asbestosis.” Plaques are markers of exposure on the pleura. They do not involve the lung tissue and, according to Cleveland Clinic, usually cause no symptoms. Many people with plaques never develop fibrosis.

“If the scan is stable, I can skip the breathing tests.” Gas transfer often falls before imaging changes. The two tests catch different things, which is why both are used.

“There is nothing to be done, so follow-up is pointless.” Scarring cannot be reversed, but oxygen prescription, rehabilitation, vaccination, smoking cessation and prompt cancer investigation all depend on the information follow-up produces.

“A normal blood test means my lungs are fine.” No blood test measures fibrosis. A reassuring blood panel says nothing about the lungs.

“I stopped working with asbestos decades ago, so I am past the risk.” The NHS puts typical onset at 20 to 30 years after exposure, and cancer risk persists lifelong. Time since exposure is a reason for vigilance, not reassurance.

“More scans are always safer.” CT radiation accumulates, and scans of people without disease produce false alarms. The right number of scans is the number that answers a clinical question.

Questions to ask your care team at follow-up

A follow-up visit is short, and the most useful questions are the ones that clarify your own plan rather than the disease in general. Consider bringing a few of these, written down.

• Based on my scans and breathing tests, do I have asbestosis, pleural disease, or exposure without disease, and what would move me between those categories?
• Which of my numbers are you watching most closely, and what change in them would prompt earlier review or further imaging?
• How often will I have breathing tests, and how often imaging, and why that balance?
• Are my oxygen levels normal at rest, on exertion and overnight, and have all three been checked?
• Do I meet criteria for low-dose CT lung cancer screening, and if so, what happens after a positive result?
• Would pulmonary rehabilitation be appropriate for me now, and how do I access it?
• Are my influenza, pneumococcal and other recommended vaccinations up to date?
• If I still smoke, what support can you offer, and who prescribes and monitors it?
• What new symptoms should make me contact you before the next appointment, and how do I reach the team?
• Should I be assessed for eligibility for occupational or industrial disease support schemes in my area, and who can advise?
• Is there a clinical trial or research study relevant to my situation?

Write the answers down or ask for them in your clinic letter. The value of follow-up compounds over years, and a clear record of what was said and why makes each subsequent visit shorter and more useful. If a family member attends with you, agree beforehand who will ask what; two sets of ears catch more than one.

When to call your doctor

Scheduled follow-up assumes that changes between visits will be reported as they happen. Some warrant a call to the team within days; others need urgent care the same day.

Contact your care team promptly, without waiting for the next appointment, if you notice breathlessness that has worsened over a few weeks so that everyday tasks feel harder, a change in your usual cough or new sputum, chest or shoulder pain that persists, unexplained weight loss, new ankle swelling, or a hoarse voice that lasts more than a few weeks. Any new symptom in someone with asbestos exposure is investigated rather than watched, because lung cancer and mesothelioma can present subtly.

Seek emergency care the same day if you cough up blood, if breathlessness comes on suddenly or is severe at rest, if you develop sharp chest pain with breathing, if your lips or fingertips look blue or gray, if you feel confused or unusually drowsy, or if a fever and productive cough are accompanied by rapid breathing. Sudden breathlessness in someone with scarred lungs can indicate a pneumothorax, a collapsed lung, a clot in the lung, or a severe infection, all of which need immediate assessment.

If you use home oxygen and your usual flow no longer keeps your readings in the range your team set, that is a reason to call, not to adjust the setting yourself.

Keep the clinic’s contact details somewhere visible, and tell whoever you live with what the red flags are. Every decision about investigation and treatment sits with the treating team; your job is to make sure they hear about a change early enough to act on it.

Frequently asked questions

How often should a follow-up medical exam be conducted for asbestos exposure?

There is no single interval that applies to everyone. The NHS and Mayo Clinic describe regular reviews with breathing tests and imaging at intervals the care team sets. Many services review stable, mild asbestosis about once a year, see progressive disease more often, and review exposure without disease at longer intervals. Ask your team what finding would bring you back sooner.

What are the first signs of asbestosis?

The earliest sign is often a scan finding in someone with no symptoms. When symptoms develop, the NHS describes gradual breathlessness on exertion, a persistent dry cough and sometimes fatigue or chest tightness, typically 20 to 30 years after exposure. These are nonspecific, so anyone with an asbestos history and new breathing changes should be assessed rather than self-diagnose.

What are the common lung findings in patients with asbestosis?

Clinicians typically find fine crackles at both lung bases, reduced chest expansion and, in longer-standing disease, finger clubbing. Imaging shows scarring concentrated in the lower and outer lungs, often with pleural plaques. Lung function shows a reduced forced vital capacity and a lowered gas transfer. These features overlap with other fibrotic lung diseases, so exposure history is central to the diagnosis.

Does asbestosis show up in a blood test?

No. Asbestosis is structural scarring of lung tissue, and no blood test detects it or measures its extent. Blood tests used in follow-up, such as an arterial blood gas, assess oxygen and carbon dioxide levels or general health before procedures. Research blood markers for mesothelioma exist but are not accurate enough for routine screening outside clinical trials.

Which asbestosis lung function tests are done at follow-up?

Spirometry measures the volume of air you can exhale, which falls as scarring restricts the lungs. Gas transfer, or DLCO, measures how easily gas crosses from the air sacs into blood and is often the first value to decline. Many services add a six-minute walk test with oxygen monitoring and, at baseline, full lung volumes measured in a sealed booth.

What do asbestosis chest X-ray findings look like compared with CT?

On X-ray, asbestosis appears as fine linear shadows in the lower zones, sometimes with calcified pleural plaques, but early disease is often missed. High-resolution CT shows subpleural lines, honeycombing and traction changes in fine detail and is far more sensitive for early scarring, pleural disease and new nodules. CT is used selectively because its radiation dose is higher.

Can asbestosis get better with time or treatment?

Established scarring does not reverse, and no medicine is proven to remove it. The condition is usually slowly progressive, though the pace varies widely and some people remain stable for years. Management focuses on slowing decline through smoking cessation, treating low oxygen, pulmonary rehabilitation, vaccination and early investigation of complications. Decisions about any treatment rest with the treating team.

Do people with asbestosis get screened for lung cancer?

Screening is decided individually. Low-dose CT lung cancer screening programs generally set eligibility by age and smoking history, and a history of asbestos exposure may strengthen the case. Routine follow-up imaging is also read with cancer in mind, and any new nodule or mass is investigated. There is currently no screening test shown to reduce deaths from mesothelioma.

Why do I need an echocardiogram if my problem is in my lungs?

Chronic low oxygen narrows the blood vessels within the lungs, raising the pressure the right side of the heart pumps against. Over years this can cause pulmonary hypertension and strain on the right ventricle. An echocardiogram, an ultrasound of the heart, estimates those pressures and checks heart function. It is ordered when symptoms, oxygen readings or an electrocardiogram suggest the heart may be affected.

What is the difference between pleural plaques and asbestosis?

Pleural plaques are patches of thickening on the membrane lining the chest wall and are markers of past asbestos exposure; they do not involve the lung tissue and usually cause no symptoms. Asbestosis is scarring within the lung itself that reduces lung volume and oxygen transfer. A person can have plaques without asbestosis, and many with plaques never develop it.

References

• Asbestosis (MedlinePlus Medical Encyclopedia)
• Asbestosis (NHS)
• Asbestos: elimination of asbestos-related diseases (WHO fact sheet)

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.